RecruitingNot applicableNCT07171320

The Efficacy and Safety of Pregabalin Combined With Desvenlafaxine in Patients With Fibromyalgia

Studying Neuromuscular disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beijing Tiantan Hospital
Intervention
Pregabalin(drug)
Enrollment
384 target
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (1)

Collaborators

Jiujiang University Affiliated Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07171320 on ClinicalTrials.gov

Other trials for Neuromuscular disease

Additional recruiting or active studies for the same condition.

See all trials for Neuromuscular disease

← Back to all trials